The DESTINY-Breast09 phase 3 trial evaluated Trastuzumab deruxtecan (Enhertu) in the first-line treatment of HER2-positive advanced breast cancer, compared with the standard CLEOPATRA regimen. In this episode of Oncology Here & Now, Dr. Erika Hamilton and Dr. Elisa Agostinetto discuss the management of patients with HER2-positive advanced breast cancer, including first-line standards like the CLEOPATRA regimen and the latest DestinyBreast09 results from ASCO, and practical strategies for patient
The DESTINY-Breast09 phase 3 trial evaluated Trastuzumab deruxteca…
257 views2 months ago
FacebookOncoAlert
Trastuzumab Deruxtecan (T-DXd) in HER2 mCRC
Trastuzumab Deruxtecan (T-DXd) in HER2 mCRC
Apr 25, 2024
onclive.com
Dr Raghav on Trastuzumab Deruxtecan in HER2 mCRC | OncLive
Dr Raghav on Trastuzumab Deruxtecan in HER2 mCRC | OncL…
Jun 4, 2023
onclive.com
Dr. Peters Discusses Ongoing Research With Trastuzumab Deruxtecan in NSCLC | OncLive
Dr. Peters Discusses Ongoing Research With Trastuzumab Deru…
Jul 2, 2020
onclive.com
Trastuzumab Deruxtecan Shows Clinical Activity in HER2 Solid Tumors
Trastuzumab Deruxtecan Shows Clinical Activity in HER2 Solid Tu…
Aug 7, 2023
targetedonc.com
Trastuzumab Deruxtecan for Patients With HER2 Metastatic Breast Cancer (mBC) | OncLive
Trastuzumab Deruxtecan for Patients With HER2 Metastatic Bre…
Nov 2, 2023
onclive.com
FDA Approves First Targeted Drug To Treat HER2-Low Breast Cancer: Trastuzumab Deruxtecan (T-DXd)
FDA Approves First Targeted Drug To Treat HER2-Low Breast Cancer…
Aug 5, 2022
mskcc.org
DESTINY-04 Changes Practice: Incorporating Trastuzumab Deruxt…
Jun 6, 2022
oncologynewscentral.com
VIDEO: Trastuzumab deruxtecan plus pertuzumab improves surviv…
6 months ago
healio.com
Dr. Raghav on Potential Combinations With Trastuzumab …
Jan 28, 2022
onclive.com
Dr. Bazhenova on Questions With Trastuzumab Deruxtecan in HER2 …
Feb 9, 2022
onclive.com
Dr. Powell on Managing Trastuzumab Deruxtecan–Induce…
May 21, 2021
onclive.com
Dr. Basho on the Integration of Trastuzumab Deruxtecan in HER2 …
Jul 22, 2021
onclive.com
Dr. Sam on Managing ILD With Trastuzumab Deruxtecan in HER2 …
Aug 3, 2021
onclive.com
Dr Hilton on the Impact of Trastuzumab Deruxtecan in HER2 …
May 19, 2023
onclive.com
Dr Meric-Bernstam on the Use of Trastuzumab Deruxtecan in HER2 …
Jun 7, 2023
onclive.com
Dr. Conlin on the Benefits of Trastuzumab Deruxtecan in HER2 …
Nov 17, 2022
onclive.com
Dr. Wesolowski on the Potential Future Utility of Trastuzumab Deru…
May 10, 2021
onclive.com
Clinical Scenario 1: A HER2 mBC Patient With Trastuzumab Deruxte…
Dec 24, 2024
onclive.com
Dr. Ueno on Patient-Reported Outcomes With Trastuzumab Deru…
Oct 26, 2022
onclive.com
Dr. Traina on the FDA Approval of Trastuzumab Deruxtecan for HER…
Dec 21, 2019
onclive.com
Dr. Iyengar on the Benefit of Trastuzumab Deruxtecan in Metas…
Jan 24, 2023
onclive.com
Everything You Should Know About Enhertu for Breast Cancer
3 months ago
health.com
ENHERTU® Approved in the U.S. for HER2 Positive Unresectable or Me…
Jan 5, 2021
businesswire.com
Enhertu: drug approved for advanced cancers – here’s what y…
8 months ago
inkl.com
Enhertu: drug approved for advanced cancers – here’s what y…
8 months ago
theconversation.com
An Expert Explains the Enhertu Approval in HER2-Low and -Ultral…
10 months ago
curetoday.com
AZN : Enhertu Approved In U.S. As First HER2 Directed Therapy For H…
Aug 12, 2022
nasdaq.com
Patritumab Deruxtecan (HER3-DXd) in EGFR-Mutated NSCLC Followin…
Oct 6, 2023
onclive.com
6:21
Revolutionizing HER2+ Breast Cancer Treatment: Trastuzumab D…
1 views1 month ago
YouTubeScholars Conferences Limited
See more videos
Static thumbnail place holder